Evercore ISI and Digital Therapeutics Alliance to Host DTx Leaders at HLTH 2022
November 10 2022 - 8:00AM
Business Wire
Panels will focus on new healthcare vertical at
annual event in Las Vegas, November 13
Evercore (NYSE: EVR) and the Digital Therapeutics Alliance (DTA)
will co-host a program on digital therapeutics November 13-16 in
Las Vegas at HLTH 2022, presented by HLTH, the leading platform
bringing together the health ecosystem. This is Evercore’s fourth
consecutive year hosting at HLTH but its first year collaborating
with thought leaders from DTA to bring awareness to a relatively
new healthcare vertical.
The program, Digital Therapeutics: An Industry is Growing Up
& Breaking Out!, is set for 10 a.m.-1 p.m. PST on Sunday,
November 13, at the Venetian Expo in Las Vegas. Five panels of
leading industry executives will discuss product launch, commercial
reimbursement, pharma partnerships, regulatory developments and
insights into the international landscape of DTx, or software-based
therapeutic interventions.
“Digital therapeutics, now several years in, continues to prove
to be the new innovative chapter for patient care,” said Elizabeth
Anderson, Evercore ISI’s Healthcare Technology & Distribution
analyst. “Now that the initial exuberance has settled, we look to
shine a light on secular trends related to improving coverage and
payor reimbursement for a treatment that has promising health
outcomes and clear economic value.”
Andy Molnar, CEO of DTA, said, “We are thrilled to partner with
Evercore at HLTH to explore the latest trends and topics in digital
therapeutics with industry trailblazers from the Digital
Therapeutics Alliance community. This collaboration will help build
connections with other innovators from the wider healthcare
ecosystem to advance DTx adoption, and ultimately transform global
healthcare.”
HLTH President Rich Scarfo noted that Evercore’s program content
has become an anticipated staple at the platform’s annual event and
consistently reflects the audience’s trends of interest. “We are
pleased to have Evercore return to HLTH this year with a timely
program focused on the evolution of digital therapeutics and how to
successfully partner with pharma,” he said.
For more information, please visit
https://www.hlth.com/2022event/partner-programs/evercore-isi.
About Evercore
Evercore (NYSE: EVR) is a premier global independent investment
banking advisory firm. We are dedicated to helping our clients
achieve superior results through trusted independent and innovative
advice on matters of strategic significance to boards of directors,
management teams and shareholders, including mergers and
acquisitions, strategic shareholder advisory, restructurings and
capital structure. Evercore also assists clients in raising public
and private capital and delivers equity research and equity sales
and agency trading execution, in addition to providing wealth and
investment management services to high-net-worth and institutional
investors. Founded in 1995, the firm is headquartered in New York
and maintains offices and affiliate offices in major financial
centers in North America, Europe and Asia. For more information,
please visit www.evercore.com.
About HLTH
HLTH (pronounced “health”) is the leading platform bringing
together the entire health ecosystem, focused on health innovation
and transformation. From unparalleled events with industry-leading
speakers to inspirational digital content and mission-driven
initiatives, HLTH creates a unique marketplace for the health
community, leading the dialogue and development of a new health
ecosystem.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20221110005440/en/
Evercore Business: Elizabeth Anderson Healthcare
Technology & Distribution analyst, Evercore ISI
1.212.446.5632
Media: Jamie Easton Head of Communications & External
Affairs Communications@Evercore.com
Evercore (NYSE:EVR)
Historical Stock Chart
From Mar 2024 to Apr 2024
Evercore (NYSE:EVR)
Historical Stock Chart
From Apr 2023 to Apr 2024